Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2012-10, Vol.159 (2), p.252-255
Hauptverfasser:	Ferreri, Andrés J. M., Bruno Ventre, Marta, Donadoni, Giovanni, Cattaneo, Chiara, Fumagalli, Luca, Foppoli, Marco, Mappa, Silvia, Govi, Silvia, Nicola, Massimo Di, Rossi, Giuseppe, Tirelli, Umberto, Caligaris-Cappio, Federico, Spina, Michele, Re, Alessandro
Format:	Artikel
Sprache:	eng
Schlagworte:	acquired immunodeficiency syndrome Adult Antineoplastic Combined Chemotherapy Protocols - administration & dosage autologous transplant Biological and medical sciences burkitt lymphoma Burkitt Lymphoma - complications Burkitt Lymphoma - therapy Carmustine - administration & dosage Cytarabine - administration & dosage Female Hematologic and hematopoietic diseases HIV Seropositivity - complications HIV Seropositivity - therapy human immunodeficiency virus Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Melphalan - administration & dosage Middle Aged non-Hodgkin lymphoma Podophyllotoxin - administration & dosage Stem Cell Transplantation Transplantation, Autologous Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!